Seminal Plasma Inhibin (67-94) (human)
Seminal Plasma Inhibin (67-94) (human) structure
|
Common Name | Seminal Plasma Inhibin (67-94) (human) | ||
|---|---|---|---|---|
| CAS Number | 96182-95-5 | Molecular Weight | 3299.856 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 2786.4±65.0 °C at 760 mmHg | |
| Molecular Formula | C150H240N36O43S2 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 1639.0±34.3 °C | |
| Symbol |
GHS08 |
Signal Word | Danger | |
| Name | Seminal Plasma Inhibin (67-94) (human) |
|---|---|
| Synonym | More Synonyms |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 2786.4±65.0 °C at 760 mmHg |
| Molecular Formula | C150H240N36O43S2 |
| Molecular Weight | 3299.856 |
| Flash Point | 1639.0±34.3 °C |
| Exact Mass | 3297.714111 |
| LogP | -5.48 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.633 |
| Symbol |
GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H360 |
| Precautionary Statements | P201-P308 + P313 |
| Personal Protective Equipment | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| RIDADR | NONH for all modes of transport |
|
PSP94, an upstream signaling mediator of prostasin found highly elevated in ovarian cancer.
Cell Death Dis. 5 , e1407, (2014) Ovarian cancer is a leading cause of cancer death as diagnosis is frequently delayed to an advanced stage. Effective biomarkers and screening strategies for early detection are urgently needed. In the... |
|
|
MSMB gene variant alters the association between prostate cancer and number of sexual partners.
Prostate 73(16) , 1803-9, (2013) Recently, a genetic variant (rs10993994) in the MSMB gene associated with prostate cancer (PCa) risk was shown to correlate with reduced prostate secretory protein of 94 amino acids (PSP94) levels. Al... |
|
|
Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.
Cancer Res. 63(9) , 2072-8, (2003) Prostate cancer is a common malignancy affecting men, which is often associated with skeletal metastases resulting in significant morbidity and mortality. In this hormone-dependent cancer, low levels ... |
| N-({(3S,6S,9S,12R,17R,20S,23S,26S,29S,32S,35S,38S,41S,44S,49aS)-3,6,20,38,41-Pentakis(4-aminobutyl)-26-[(2S)-2-butanyl]-35-(2-carboxyethyl)-44-(carboxymethyl)-23-(4-hydroxybenzyl)-9-[(1R)-1-hydroxyeth ;yl]-17-[(L-isoleucyl-L-phenylalanyl-L-lysyl-L-lysyl-L-α-glutamyl-L-α-aspartyl)amino]-29,32-diisopropyl-1,4,7,10,18,21,24,27,30,33,36,39,42,45-tetradecaoxohexatetracontahydro-1H-pyrrolo[2,1-p][ 1,2,5,8,11,14,17,20,23,26,29,32,35,38,41,44] |
| L-Isoleucine, N-[[(3S,6S,9S,12R,17R,20S,23S,26S,29S,32S,35S,38S,41S,44S,49aS)-17-[[(2S,5S,8S,11S,14S,17S,18S)-17-amino-8,11-bis(4-aminobutyl)-5-(2-carboxyethyl)-2-(carboxymethyl)-18-methyl-1,4,7,10,13,16-hexaoxo-14-(phenylmethyl)-3,6,9,12,15-pentaazaeicos-1-yl]amino]-3,6,20,38,41-pentakis(4-aminobutyl)-35-(2-carboxyethyl)-44-(carboxymethyl)hexatetracontahydro-9-[(1R)-1-hydroxyethyl]-23-[(4-hydroxyphenyl)methyl]-29,32-bis(1-methylethyl)-26-[ |